Open AccessSuppressive Therapy With Valacyclovir in Early Genital Herpes: A Pilot Study of Clinical Efficacy and Herpes-Related Quality of Life
Author(s) -
H. Hunter Handsfield,
Terri Warren,
Mica Werner,
James A. Phillips
Publication year - 2007
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/01.olq.0000243620.13718.56
Subject(s) - medicine , placebo , herpes simplex virus , genital herpes , valaciclovir , quality of life (healthcare) , herpes genitalis , genital warts , sexually transmitted disease , transmission (telecommunications) , viral disease , immunology , herpesviridae , virus , pathology , syphilis , alternative medicine , nursing , cervical cancer , cancer , human immunodeficiency virus (hiv) , electrical engineering , engineering
Suppressive therapy has not been studied during the first year after acquisition of genital herpes, the time of maximum frequency of reactivation, potential for transmission, and impact on quality of life.